Paulo Stanga

Paulo Stanga is the founder, CMO and lead Consultant vitreoretinal and cataract surgeon at The Retina Clinic London, and Professor of Ophthalmology at the Institute of Ophthalmology/University College London (UCL).

With over 30 years of experience in Ophthalmology and a focus on medical and surgical retina, including macular degeneration, diabetic retinopathy, vitreous floaters, cataracts, retinal laser, new therapies, surgical technology, advanced imaging and clinical studies, Professor Stanga is committed to advancing the realm of eye care and is dedicated to transforming lives through pioneering work in Ophthalmology.

Prof. Stanga has been a pioneer in ultra-widefield imaging and AI applied to retinal imaging. He has extensive experience in artificial vision and electronic retinal implants. He was one of the first surgeons to implant the Argus II in retinitis pigmentosa, was involved in the first-ever study of artificial vision and the Argus II in AMD, and successfully performed the first-in-human implantations. He is currently involved in milestone research projects for intravitreal and subretinal gene therapy in IRDs and geographic atrophy.

After leaving the NHS in 2019, Professor Stanga founded The Retina Clinic London, the UK’s first independent retina clinic with fully equipped on-site operating theatre, academic and research activities, including participation in industry sponsored clinical trials.